Prostate cancer: open trials in Switzerland

43 open trials have a site in Switzerland. Registry data; only the trial team decides who can take part.

NCT07916779
Erectile Function PRESERVation in Definitive Radiotherapy for Prostate Cancer by MRI-Enhanced Adaptive Sparing of the Neurovascular Bundle
Trial Treatment · University of Zurich
University Hospital Zurich, Zurich
Registry updated 2026-11-04
NCT06482489
Accurate Prostate Cancer Following Using Low-Field MRI (Low-PRISM)
Research · University of Lausanne Hospitals
Lausanne University Hospital, Lausanne
Registry updated 2026-10-30
NCT06925737
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Kantonspital Aarau ( Site 0857), Aarau · University Hospital Basel ( Site 0859), Basel · HFR Fribourg - Hôpital Cantonal ( Site 0858), Fribourg · Hopitaux Universitaires de Geneve HUG. ( Site 0856), Geneva · Stadtspital Zürich Triemli ( Site 0855), Zurich
Registry updated 2026-10-30
NCT07484269
PULSE Registry: for Patients Receiving Lutetium (177Lu) Vipivotide Tetraxetan
Research · Novartis Pharmaceuticals
Basel
Registry updated 2026-10-30
NCT07365423
Terbinafine for Biochemically Recurrent Prostate Cancer (TerbinaPro)
Trial Treatment · Phase 2 · Swiss Cancer Institute
Kantonsspital Baden, Baden · Universitätsspital Basel, Basel · EOC - Istituto Oncologico della Svizzera Italiana, Bellinzona · Kantonsspital Graubunden, Chur · Spital Thurgau AG, Frauenfeld · Hôpitaux Universitaires Genève HUG, Geneva · Luzerner Kantonsspital, Lucerne · TBZO Tumor- und BrustZentrum Ostschweiz - Rapperswil, Rapperswil · HOCH Health Ostschweiz - Kantonsspital St. Gallen, Sankt Gallen · Kantonsspital Winterthur, Winterthur · Universitätsspital Zürich USZ, Zurich
Registry updated 2026-10-28
NCT05946213
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Trial Treatment · Phase 3 · NRG Oncology
Kantonsspital Aarau, Aarau
Registry updated 2026-10-23
NCT05939414
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
Trial Treatment · Phase 3 · Novartis Pharmaceuticals
Geneva · Lucerne · Zurich
Registry updated 2026-10-21
NCT07213674
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
Trial Treatment · Phase 3 · Amgen
Inselspital Bern, Bern · Centre Hospitalier Universitaire Vaudois, Lausanne · Kantonsspital Sankt Gallen, Sankt Gallen · Hirslanden Zurich, Zurich
Registry updated 2026-10-20
NCT07344779
A Study to Learn How Men With Advanced Prostate Cancer Respond to Treatment With Darolutamide and Hormone Therapy, With or Without Chemotherapy, in Real-world Medical Practice
Research · Bayer
Many Locations, Many Locations
Registry updated 2026-10-19
NCT07611110
AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
Trial Treatment · Phase 3 · AstraZeneca
Bern · Geneva · Zurich
Registry updated 2026-10-19
NCT07711002
Saruparib in Combination With Physician's Choice of ARPI in Patients With mHSPC Previously Treated With Docetaxel or 177Lu-PSMA Therapy Without Disease Progression and PSA ≥ 0.2 ng/mL (EvoPAR-PR05)
Trial Treatment · Phase 3 · AstraZeneca
Aarau · Chur
Registry updated 2026-10-15
NCT07028853
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Trial Treatment · Phase 3 · Pfizer
Inselspital Bern, Bern
Registry updated 2026-10-14
NCT06401980
Darolutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Trial Treatment · Phase 2 · Swiss Cancer Institute
Tumorzentrum Aarau TZA, Aarau · Kantonsspital Baden, Baden · Istituto Oncologico della Svizzera Italiana (IOSI), Bellinzona · Inselspital, Bern · Kantonsspital Graubuenden, Chur · Hôpitaux Universitaires Genève HUG, Geneva · Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne · Luzerner Kantonsspital, Lucerne · Kantonsspital St. Gallen, Sankt Gallen · Kantonsspital Winterthur, Winterthur · Universitaetsspital Zuerich, Zurich · OnkoZentrum Zürich - Standort Seefeld, Zurich · Stadtspital Triemli Zürich, Zurich
Registry updated 2026-10-09
NCT03678025
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Trial Treatment · Phase 3 · SWOG Cancer Research Network
Kantonsspital Aarau, Aarau
Registry updated 2026-10-08
NCT05176483
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Trial Treatment · Phase 1 · Exelixis
Chur · Sankt Gallen · Winterthur
Registry updated 2026-10-01
NCT07847385
Tractography-Guided Nerve-Sparing in Prostate Cancer
Trial Treatment · Massimo Valerio
Hôpitaux Universitaires de Genève - Dept de Chirurgie - Service d'Urologie, Geneva
Registry updated 2026-09-29
NCT05489211
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
Trial Treatment · Phase 2 · AstraZeneca
Basel · Bellinzona · Sankt Gallen
Registry updated 2026-09-23
NCT06780670
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
Trial Treatment · Phase 2/3 · Novartis Pharmaceuticals
Basel · Bellinzona · Bern
Registry updated 2026-09-22
NCT07826858
SPECTRA: Intraoperative Hyperspectral Imaging for Prostate Cancer
Trial Treatment · Massimo Valerio
Hôpitaux Universitaires de Genève - Dept de Chirurgie - Service d'Urologie, Geneva
Registry updated 2026-09-17
NCT07002320
Investigating SX-682 in Combination With Apalutamide in Metastatic Castration-resistant Prostate Cancer
Trial Treatment · Phase 1/2 · Institute of Cancer Research, United Kingdom
Oncology Institute of Southern Switzerland, Bellinzona
Registry updated 2026-09-08
NCT07782112
Best Salvage Treatment for High-risk Relapsing Prostate Cancer (PEACE-9 - ESCALATE-RT)
Trial Treatment · Phase 3 · Ente Ospedaliero Cantonale, Bellinzona
KSA, Aarau · IOSI-EOC, Bellinzona · Inselspital, Bern · KSGR, Chur · Spital Thurgau, Münsterlingen · KSW, Winterthur · USZ, Zurich
Registry updated 2026-08-24
NCT04221542
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
Trial Treatment · Phase 1 · Amgen
Istituto Oncologico della Svizzera Italiana, Bellinzona · Kantonsspital Graubuenden, Chur · Centre Hospitalier Universitaire Vaudois, Lausanne · Kantonsspital Sankt Gallen, Sankt Gallen
Registry updated 2026-08-21
NCT07591051
Weekly Online CT or MR Adaptive Definitive SBRT for Regionally Metastatic Prostate Cancer
Trial Treatment · University of Zurich
University Hospital Zurich, Zurich
Registry updated 2026-08-21
NCT07762911
Evaluation of an MRI-based Prostate Cancer Screening Program (VISIONING): 5-Year Follow-up Round (VISIONING III)
Trial Treatment · University Hospital, Basel, Switzerland
University Hospital Basel, Urology, Basel
Registry updated 2026-08-13
NCT07705074
FAPI PET Imaging - An Exploratory Study
Trial Treatment · Phase 1/2 · Martin Huellner
Kantonsspital Baden, Baden · Hôpitaux Universitaires de Genève (HUG), Geneva · Clinique de Genolier, Genolier · Luzerner Kantonsspital, Lucerne · Department for Nuclear Medicine, University Hospital Zurich, Zurich
Registry updated 2026-07-15

All Prostate cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error